153 related articles for article (PubMed ID: 33745436)
1. The Role of Machine Learning in Centralized Authorization Process of Nanomedicines in European Union.
Santana R; Onieva E; Zuluaga R; Duardo-Sánchez A; Gañán P
Curr Top Med Chem; 2021; 21(9):828-838. PubMed ID: 33745436
[TBL] [Abstract][Full Text] [Related]
2. Machine Learning as a Proposal for a Better Application of Food Nanotechnology Regulation in the European Union.
Santana R; Onieva E; Zuluaga R; Duardo-Sánchez A; Gañán P
Curr Top Med Chem; 2020; 20(4):324-332. PubMed ID: 31804168
[TBL] [Abstract][Full Text] [Related]
3. [The use of nanotechnology in medicinal products in the light of European Union law].
Jurewicz M
Pol Merkur Lekarski; 2014 Dec; 37(222):369-72. PubMed ID: 25715580
[TBL] [Abstract][Full Text] [Related]
4. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning and Perturbation Theory Machine Learning (PTML) in Medicinal Chemistry, Biotechnology, and Nanotechnology.
Herrera-Ibatá DM
Curr Top Med Chem; 2021; 21(7):649-660. PubMed ID: 33475073
[TBL] [Abstract][Full Text] [Related]
6. European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States.
Qu L; Zou W; Wang Y; Wang M
Phytomedicine; 2018 Mar; 42():219-225. PubMed ID: 29655689
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicines in the EU-Regulatory Overview.
Pita R; Ehmann F; Papaluca M
AAPS J; 2016 Nov; 18(6):1576-1582. PubMed ID: 27527889
[TBL] [Abstract][Full Text] [Related]
8. Merging data curation and machine learning to improve nanomedicines.
Chen C; Yaari Z; Apfelbaum E; Grodzinski P; Shamay Y; Heller DA
Adv Drug Deliv Rev; 2022 Apr; 183():114172. PubMed ID: 35189266
[TBL] [Abstract][Full Text] [Related]
9. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
Kroes BH
J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
[TBL] [Abstract][Full Text] [Related]
10. [A proposal for reforming psychologists' training in France and in the European Union].
Bouchard JP
Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
[TBL] [Abstract][Full Text] [Related]
11. Development and regulation of biosimilars: current status and future challenges.
Tsiftsoglou AS; Ruiz S; Schneider CK
BioDrugs; 2013 Jun; 27(3):203-11. PubMed ID: 23553340
[TBL] [Abstract][Full Text] [Related]
12. Machine learning-integrated omics for the risk and safety assessment of nanomaterials.
Ahmad F; Mahmood A; Muhmood T
Biomater Sci; 2021 Mar; 9(5):1598-1608. PubMed ID: 33443512
[TBL] [Abstract][Full Text] [Related]
13. Predicting coated-nanoparticle drug release systems with perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2020 Jul; 12(25):13471-13483. PubMed ID: 32613998
[TBL] [Abstract][Full Text] [Related]
14. Perturbation-Theory and Machine Learning (PTML) Model for High-Throughput Screening of Parham Reactions: Experimental and Theoretical Studies.
Simón-Vidal L; García-Calvo O; Oteo U; Arrasate S; Lete E; Sotomayor N; González-Díaz H
J Chem Inf Model; 2018 Jul; 58(7):1384-1396. PubMed ID: 29898360
[TBL] [Abstract][Full Text] [Related]
15. Taking temperature--a review of European Union regulation in nanomedicine.
D'Silva J; van Calster G
Eur J Health Law; 2009 Sep; 16(3):249-69. PubMed ID: 19788003
[TBL] [Abstract][Full Text] [Related]
16. Perturbation Theory Machine Learning Models: Theory, Regulatory Issues, and Applications to Organic Synthesis, Medicinal Chemistry, Protein Research, and Technology.
Arrasate S; Duardo-Sanchez A
Curr Top Med Chem; 2018; 18(14):1203-1213. PubMed ID: 30095052
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of difficult problems on European Union laws and regulations of traditional herbal medicinal products].
Qu LP; Zhang XQ; Xiong Y; Wang YT; Zou WJ
Zhongguo Zhong Yao Za Zhi; 2017 Oct; 42(20):4040-4044. PubMed ID: 29243444
[TBL] [Abstract][Full Text] [Related]
18. Medicinal plants and their preparations in the European market: Why has the harmonization failed? The cases of St. John's wort, valerian, ginkgo, ginseng, and green tea.
Bilia AR; Costa MDC
Phytomedicine; 2021 Jan; 81():153421. PubMed ID: 33291029
[TBL] [Abstract][Full Text] [Related]
19. [Interpretation of Guidelines on Good Pharmacovigilance Practices for European Union].
Xie YM; Tian F
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2963-8. PubMed ID: 24471312
[TBL] [Abstract][Full Text] [Related]
20. Designing nanoparticle release systems for drug-vitamin cancer co-therapy with multiplicative perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2019 Nov; 11(45):21811-21823. PubMed ID: 31691701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
